Stocklytics Platform
Asset logo for symbol XRAY
DENTSPLY SIRONA
XRAY52
$25.82arrow_drop_down1.03%-$0.27
Asset logo for symbol XRAY
XRAY52

$25.82

arrow_drop_down1.03%

Is XRAY a Buy or Sell based on AI Analysis?

Fundamental Analysis

DENTSPLY SIRONA Inc (XRAY) has a strong market position with a market cap of $7.05B and a healthy revenue of $3.94B. The company's gross margin of 52.87% and operating margin of 7.02% indicate efficient cost management and profitability. Additionally, DENTSPLY SIRONA Inc has a dividend yield of 1.92%, suggesting a commitment to rewarding shareholders with steady returns. The company's price to sales ratio of 1.78 and price to book ratio of 2.14 indicate that the stock may be undervalued compared to its competitors in the healthcare sector. However, there are some areas of concern in the company's fundamental analysis. DENTSPLY SIRONA Inc has a negative net income of -$132M, indicating potential financial challenges. The company's return on equity of -3.72% also raises questions about its ability to generate profits for shareholders. Additionally, the high price to free cash flow ratio of 30.92 and price to cashflow ratio of 18.7 suggest that the company may be overvalued based on its cash flow performance. Investors should carefully consider these factors when making investment decisions related to DENTSPLY SIRONA Inc.

Positive Development

Despite facing some losses, Dentsply Sirona Inc. (XRAY) has shown a consistent performance in outperforming its competitors. This indicates a strong competitive position and potential for future growth. The company has reported a modest revenue growth amidst a net loss for FY23, which could suggest a potential recovery in demand for its products. The company has also reported a dividend increase and provided a FY24 outlook, which could indicate a positive outlook for the company's future growth.

Negative Development

Despite outperforming its competitors, Dentsply Sirona Inc. (XRAY) has underperformed on several days, indicating potential weaknesses in its stock price. The company's EPS is negative, which could indicate potential financial difficulties. The company's current ratio is less than 1.5, indicating a high level of current liabilities compared to its assets, which could be a concern for its short-term liquidity. The company's long-term debt to total asset ratio is 0.2504, indicating a high level of debt compared to its assets, which could be a concern for its long-term financial sustainability.

Technical Analysis

DENTSPLY SIRONA Inc, a healthcare company, currently has a neutral technical rating. The stock has one technical buy indicator for the month, which is ATR, and seven technical hold indicators including RSI, MACD, CCI, ADX, WILLR, ROC, and STOCHRSI. This suggests a mixed signal in terms of technical analysis, indicating a potential consolidation or uncertainty in the stock's price movement in the near term. Additionally, the stock's market sector in healthcare has seen a significant change of 28.41% over the past year, while the overall stock market has seen a 37.85% change over the same period. With a cumulative multiple of 12 and a beta of 1, DENTSPLY SIRONA Inc may be considered a moderately volatile stock. The company's technical indicators also show a score of 56 in the market, suggesting a neutral stance among analysts and market participants regarding the stock's future price performance.

Conclusion and recommendation

Based on the data provided about DENTSPLY SIRONA Inc, it is evident that the company has a neutral analyst recommendation and a dividend yield of 1.92%. The stock has a market capitalization of $7.05 billion and a price-to-sales ratio of 1.78. With a beta of 1, the stock is considered to have average volatility compared to the market. Additionally, the company has a solid gross margin of 52.87% and a free cash flow margin of 5.79%. In conclusion, DENTSPLY SIRONA Inc appears to be a stable investment option with consistent revenue and a strong market presence in the healthcare sector. Despite a negative return on equity of -3.72%, the company's overall financial health seems sound with a current ratio of 1.38 and a manageable debt-to-equity ratio of 0.7. Investors may consider this stock for a long-term investment strategy, especially given its dividend-paying history and relatively stable earnings growth. However, it is essential to keep an eye on market trends and industry developments to make informed decisions regarding this stock.

Data refers to:February 28, 2024
Public
or to generate AI stock Analysis for DENTSPLY SIRONA (Powered by our data and Chat GPT 4).
Disclaimer
This AI-generated analysis is provided for informational purposes only and should not be considered as investment advice. The analysis is an experimental feature, and the information contained herein is derived from various sources and AI algorithms, which may not be entirely accurate or complete. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. The author and the platform providing this analysis assume no responsibility for any losses or damages resulting from the use of this analysis or the information contained within.
About AI-Powered Analysis
Powered by the advanced GPT-4 engine developed by OpenAI, a leading organization in artificial intelligence research, our AI-conducted stock analysis provides a comprehensive and actionable view of the stock market. This approach covers both technical and fundamental aspects, integrating relevant news developments, analysts' price targets, and predictions for upcoming trading periods into a clear and concise summary. This ensures a rounded perspective on a stock's performance and its potential, enhancing the understanding and the decision-making process for investors.
Share your feedback

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media